As of April 19, 2025, Aadi Bioscience (AADI) has a market cap of $94.892 million USD. According to our data, Aadi Bioscience is ranked No.7626 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $94.89 M |
21.78%
|
Dec 31, 2024 | $77.92 M |
56.19%
|
Dec 29, 2023 | $49.89 M |
-84.26%
|
Dec 30, 2022 | $0.32 B |
-46.87%
|
Dec 31, 2021 | $0.60 B |
64.29%
|
Dec 31, 2020 | $0.36 B |
57.05%
|
Dec 31, 2019 | $0.23 B |
-63.29%
|
Dec 31, 2018 | $0.63 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.41 B |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Exelixis
EXEL
|
$9.97 B |
-0.000 M
|
![]() USA
|
![]() Karyopharm Therapeutics
KPTI
|
$42.42 M |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.80 B |
-0.000 M
|
![]() Canada
|
![]() Iovance Biotherapeutics
IOVA
|
$1.00 B |
-0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Syndax Pharmaceuticals
SNDX
|
$0.99 B |
0.000 M
|
![]() USA
|
![]() Verastem Oncology
VSTM
|
$0.30 B |
-0.000 M
|
![]() USA
|
![]() OncoCyte
OCX
|
$81.22 M |
-0.000 M
|
![]() USA
|
Market Cap | = | AADI Stock Price | * | AADI Shares Outstanding |
= | $1.95 | * | 46.29 M | |
= | $94.89 M |